Heritable human genome editing - making changes to the genetic material of eggs, sperm, or any cells that lead to their development, including the cells of early embryos, and establishing a pregnancy - raises not only scientific and medical considerations but also a host of ethical, moral, and societal issues. Human embryos whose genomes have been edited should not be used to create a pregnancy until it is established that precise genomic changes can be made reliably and without introducing undesired changes - criteria that have not yet been met, says Heritable Human Genome Editing.
From an international commission of the U.S. National Academy of Medicine, U.S. National Academy of Sciences, and the U.K.'s Royal Society, the report considers potential benefits, harms, and uncertainties associated with genome editing technologies and defines a translational pathway from rigorous preclinical research to initial clinical uses, should a country decide to permit such uses. The report specifies stringent preclinical and clinical requirements for establishing safety and efficacy, and for undertaking long-term monitoring of outcomes. Extensive national and international dialogue is needed before any country decides whether to permit clinical use of this technology, according to the report, which identifies essential elements of national and international scientific governance and oversight.
Table of Contents |
skim chapter | |
|---|---|---|
| Front Matter | i-xviii | |
| Summary | 1-18 | |
| 1 Introduction | 19-34 | |
| 2 The State of the Science | 35-94 | |
| 3 Potential Applications of Heritable Human Genome Editing | 95-120 | |
| 4 A Translational Pathway to Limited and Controlled Clinical Applications of Heritable Human Genome Editing | 121-144 | |
| 5 National and International Governance of Heritable Human Genome Editing | 145-168 | |
| References | 169-186 | |
| Appendix A: Information Sources and Methods | 187-192 | |
| Appendix B: Commissioner Biographies | 193-202 | |
| Appendix C: Glossary | 203-214 | |
| Appendix D: Acronyms and Abbreviations | 215-218 | |
| Acknowledgment of Reviewers | 219-220 | |
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
Click here to obtain permission for Heritable Human Genome Editing.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Loading stats for Heritable Human Genome Editing...
Finding similar items...
